<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34253126</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>27</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1744-7631</ISSN><JournalIssue CitedMedium="Internet"><Volume>25</Volume><Issue>6</Issue><PubDate><Year>2021</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Expert opinion on therapeutic targets</Title><ISOAbbreviation>Expert Opin Ther Targets</ISOAbbreviation></Journal><ArticleTitle>Enteroviruses and coronaviruses: similarities and therapeutic targets.</ArticleTitle><Pagination><StartPage>479</StartPage><EndPage>489</EndPage><MedlinePgn>479-489</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1080/14728222.2021.1952985</ELocationID><Abstract><AbstractText><b>Introduction</b>: Enteroviruses are common viruses causing a huge number of acute and chronic infections and producing towering economic costs. Similarly, coronaviruses cause seasonal mild infections, epidemics, and even pandemics and can lead to severe respiratory symptoms. It is important to develop broadly acting antiviral molecules to efficiently tackle the infections caused by thes.<b>Areas covered</b>: This review illuminates the differences and similarities between enteroviruses and coronaviruses and examines the most appealing therapeutic targets to combat both virus groups. Publications of both virus groups and deposited structures discovered through PubMed to March 2021 for viral proteases have been evaluated.<b>Expert opinion</b>: The main protease of coronaviruses and enteroviruses share similarities in their structure and function. These proteases process their viral polyproteins and thus drugs that bind to the active site have potential to target both virus groups. It is important to develop drugs that target more evolutionarily conserved processes and proteins. Moreover, it is a wise strategy to concentrate on processes that are similar between several virus families.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Marjom&#xe4;ki</LastName><ForeName>Varpu</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kalander</LastName><ForeName>Kerttu</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hellman</LastName><ForeName>Maarit</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Permi</LastName><ForeName>Perttu</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-6281-1138</Identifier><AffiliationInfo><Affiliation>Department of Biological and Environmental Science/Nanoscience Center, University of Jyv&#xe4;skyl&#xe4;, Jyv&#xe4;skyl&#xe4;, Finland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>07</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Expert Opin Ther Targets</MedlineTA><NlmUniqueID>101127833</NlmUniqueID><ISSNLinking>1472-8222</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber><NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017934" MajorTopicYN="N">Coronavirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004770" MajorTopicYN="N">Enterovirus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013379" MajorTopicYN="N">Substrate Specificity</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">3C protease</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Enterovirus</Keyword><Keyword MajorTopicYN="N">SARS-COV-2</Keyword><Keyword MajorTopicYN="N">coronavirus</Keyword><Keyword MajorTopicYN="N">main protease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>7</Month><Day>13</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>7</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34253126</ArticleId><ArticleId IdType="pmc">PMC8330013</ArticleId><ArticleId IdType="doi">10.1080/14728222.2021.1952985</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marjomaki V, Turkki P, Huttunen M.. Infectious entry pathway of enterovirus B species. Viruses. 2015;7(12):6387&#x2013;6399.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4690868</ArticleId><ArticleId IdType="pubmed">26690201</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C, Siegrist F, Petty TJ, et al. Picornavirus and enterovirus diversity with associated human diseases. Infect Genet Evol. 2013;14:282&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">23201849</ArticleId></ArticleIdList></Reference><Reference><Citation>Huber S, Ramsingh AI. Coxsackievirus-Induced Pancreatitis. Viral Immunol. 2004;17:358&#x2013;369.</Citation><ArticleIdList><ArticleId IdType="pubmed">15357902</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Honkanen H, Pakkanen O, et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014;63:446&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">23974921</ArticleId></ArticleIdList></Reference><Reference><Citation>Roivainen M, Alfthan G, Jousilahti P, et al. Enterovirus infections as a possible risk factor for myocardial infarction. Circulation. 1998;98:2534&#x2013;2537.</Citation><ArticleIdList><ArticleId IdType="pubmed">9843459</ArticleId></ArticleIdList></Reference><Reference><Citation>International Committee on Taxonomy of Viruses . ICTV master species list 2019 v2. Checklist dataset; 2019. doi:10.15468/i4jnfv. Available from: https://www.gbif.org/dataset/e01b0cbb-a10a-420c-b5f3-a3b20cc266ad</Citation><ArticleIdList><ArticleId IdType="doi">10.15468/i4jnfv</ArticleId></ArticleIdList></Reference><Reference><Citation>Harvala H, Jasir A, Penttinen P, et al. Surveillance and laboratory detection for non-polio enteroviruses in the European Union/European Economic Area, 2016. Euro Surveill. 2017;22. DOI:10.2807/1560-00807.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-00807</ArticleId><ArticleId IdType="pmc">PMC5718392</ArticleId><ArticleId IdType="pubmed">29162204</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Clusters of acute respiratory illness associated with human enterovirus 68 &#x2014;Asia, Europe, and United States, 2008 &#x2013;2010. MMWR Morb Mortal Wkly Rep. 2011;60:1301&#x2013;1304.</Citation><ArticleIdList><ArticleId IdType="pubmed">21956405</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Y, Jiang L, Peng HL. Clinical analysis of 134 children with nervous system damage caused by enterovirus 71 infection. Pediatr Infect Dis J. 2015;34:718&#x2013;723. pmid:25860536</Citation><ArticleIdList><ArticleId IdType="pubmed">25860536</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L, Tapparel C. Rhinoviruses and respiratory enteroviruses: not as simple as ABC. Viruses. 2016;8(1). DOI:10.3390/v8010016</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v8010016</ArticleId><ArticleId IdType="pmc">PMC4728576</ArticleId><ArticleId IdType="pubmed">26761027</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossmann MG, He Y, Kuhn RJ. Picornavirus-receptor interactions. Trends Microbiol. 2002;10(7):324&#x2013;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">12110211</ArticleId></ArticleIdList></Reference><Reference><Citation>Baggen J, Thibaut HJ, Strating JRPM, et al. The life cycle of non-polio enteroviruses and how to target it. Nat Rev Microbiol. 2018;16(6):368&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pubmed">29626210</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchs R, Blaas D. Uncoating of human rhinoviruses. Rev Med Virol. 2010;20(5):281&#x2013;297.</Citation><ArticleIdList><ArticleId IdType="pubmed">20629045</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuthill TJ, Groppelli E, Hogle JM, et al. Picornaviruses. Curr Top Microbiol Immunol. 2010;343:43&#x2013;89.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3018333</ArticleId><ArticleId IdType="pubmed">20397067</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim C, Bergelson JM. Echovirus 7 entry into polarized intestinal epithelial cells requires clathrin and Rab7. mBio. 2012;3(2).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3324788</ArticleId><ArticleId IdType="pubmed">22496312</ArticleId></ArticleIdList></Reference><Reference><Citation>Panjwani A, Strauss M, Gold S, et al. Capsid protein VP4 of human rhinovirus induces membrane permeability by the formation of a size-selective multimeric pore. PLoS Pathog. 2014;10(8):e1004294.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4125281</ArticleId><ArticleId IdType="pubmed">25102288</ArticleId></ArticleIdList></Reference><Reference><Citation>Staring J, von Castelmur E, Blomen VA, et al. PLA2G16 represents a switch between entry and clearance of Picornaviridae. Nature. 2017;541(7637):412&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pubmed">28077878</ArticleId></ArticleIdList></Reference><Reference><Citation>Brabec M, Schober D, Wagner E, et al. Opening of size-selective pores in endosomes during human rhinovirus serotype 2 in vivo uncoating monitored by single-organelle flow analysis. J Virol. 2005;79(2):1008&#x2013;1016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC538566</ArticleId><ArticleId IdType="pubmed">15613329</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Der Linden L, Wolthers KC, Van Kuppeveld FJ. Replication and inhibitors of enteroviruses and parechoviruses. Viruses. 2015;7(8):4529&#x2013;4562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4576193</ArticleId><ArticleId IdType="pubmed">26266417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu NY, Ilnytska O, Belov G, et al. Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell. 2010;141(5):799&#x2013;811.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2982146</ArticleId><ArticleId IdType="pubmed">20510927</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol. 1990;44:603&#x2013;623.</Citation><ArticleIdList><ArticleId IdType="pubmed">2252396</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand K, Ziebuhr J, Wadhwani P, et al. Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs. Science. 2003;300(5626):1763&#x2013;1767.</Citation><ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId></ArticleIdList></Reference><Reference><Citation>Laitinen OH, Svedin E, Kapell S, et al. Enteroviral proteases: structure, host interactions and pathogenicity. Rev Med Virol. 2016;26:251&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7169145</ArticleId><ArticleId IdType="pubmed">27145174</ArticleId></ArticleIdList></Reference><Reference><Citation>Laajala M, Hankaniemi MM, Maatta JAE, et al. Calpains can cleave structural proteins from the enterovirus polyprotein. Viruses. 2019;11. DOI:10.3390/v11121106</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v11121106</ArticleId><ArticleId IdType="pmc">PMC6950447</ArticleId><ArticleId IdType="pubmed">31795245</ArticleId></ArticleIdList></Reference><Reference><Citation>Geller R, Vignuzzi M, Andino R, et al. Evolutionary constraints on chaperone-mediated folding provide an antiviral approach refractory to development of drug resistance. Genes Dev. 2007;21:195&#x2013;205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770902</ArticleId><ArticleId IdType="pubmed">17234885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma HC, Liu Y, Wang C, et al. An Interaction between glutathione and the capsid is required for the morphogenesis of C-cluster enteroviruses. PLoS Pathog. 2014;10:e1004052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3983063</ArticleId><ArticleId IdType="pubmed">24722315</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui J, Li F, Shi ZL. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17:181&#x2013;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097006</ArticleId><ArticleId IdType="pubmed">30531947</ArticleId></ArticleIdList></Reference><Reference><Citation>V&#x2019;kovski P, Kratzel A, Steiner S, et al. Coronavirus biology and replication: implications for SARS-CoV-2. Nat Rev Microbiol. 2021;19:155&#x2013;170.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7592455</ArticleId><ArticleId IdType="pubmed">33116300</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Coronavirus (COVID-19) dashboard. [cited 2021 Apr 30]. Available from:
https://covid19.who.int/</Citation></Reference><Reference><Citation>Boopathi S, Poma AB, Kolandaivel P. Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment. J Biomol Struct Dyn. 2020;30:1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196923</ArticleId><ArticleId IdType="pubmed">32306836</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei J, Kusov Y, Hilgenfeld R. Nsp3 of coronaviruses: structures and functions of a large multi-domain protein. Antiviral Res. 2018. Jan;149:58&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113668</ArticleId><ArticleId IdType="pubmed">29128390</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J, Ge J, Yu J, et al. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature. 2020;581:215&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">32225176</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang J, Ye G, Shi K, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature. 2020;581:221&#x2013;224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7328981</ArticleId><ArticleId IdType="pubmed">32225175</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L, Ojha R, Pedro LD, et al. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science. 2020;370(6518):856&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama S, Nagata N, Shirato K, et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J Virol. 2010;84(24):12658&#x2013;12664.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3004351</ArticleId><ArticleId IdType="pubmed">20926566</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons G, Gosalia DN, Rennekamp AJ, et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc Natl Acad Sci U S A. 2005;102(33):11876&#x2013;11881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1188015</ArticleId><ArticleId IdType="pubmed">16081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Snijder EJ, Limpens RWAL, De Wilde AH, et al. A unifying structural and functional model of the coronavirus replication organelle: tracking down RNA synthesis. PLoS Biol. 2020;18(6):e3000715.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7302735</ArticleId><ArticleId IdType="pubmed">32511245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolff G, Limpens RWAL, Zevenhoven-Dobbe JC, et al. A molecular pore spans the double membrane of the coronavirus replication organelle. Science. 2020;369(6509):1395&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7665310</ArticleId><ArticleId IdType="pubmed">32763915</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuman BW, Kiss G, Kunding AH, et al. A structural analysis of M protein in coronavirus assembly and morphology. J Struct Biol. 2011;174(1):11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4486061</ArticleId><ArticleId IdType="pubmed">21130884</ArticleId></ArticleIdList></Reference><Reference><Citation>Slanina H, Madhugiri R, Bylapudi G, et al. Coronavirus replication-transcription complex: vital and selective NMPylation of a conserved site in nsp9 by the NiRAN-RdRp subunit. Proc Natl Acad Sci USA. 2021;118(6):e2022310118. .</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8017715</ArticleId><ArticleId IdType="pubmed">33472860</ArticleId></ArticleIdList></Reference><Reference><Citation>Shannon A, Fattorini V, Sama B, et al. Protein-primed RNA synthesis in SARS-CoVs and structural basis for inhibition by AT-527. bioRxiv. 2021;03:23.436564. .</Citation></Reference><Reference><Citation>Kneller DW, Phillips G, O&#x2019;Neill HM, et al. Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography. Nat Commun. 2020;11:3202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314768</ArticleId><ArticleId IdType="pubmed">32581217</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui S, Wang J, Fan T, et al . Crystal structure of human enterovirus 71 3C protease. J Mol Biol. 2011;408(3): 449&#x2013;461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094522</ArticleId><ArticleId IdType="pubmed">21396941</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Z, Du X, Xu Y, et al. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature. 2020;582:289&#x2013;293.</Citation><ArticleIdList><ArticleId IdType="pubmed">32272481</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lin D, Sun X, et al. Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved &#x3b1;-ketoamide inhibitors. Science. 2020. Apr 24;368:409&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7164518</ArticleId><ArticleId IdType="pubmed">32198291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee CC, Kuo CJ, Ko TP, et al. Structural basis of inhibition specificities of 3C and 3C-like proteases by zinc-coordinating and peptidomimetic compounds. J Biol Chem. 2009;284(12):7646&#x2013;7655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2658058</ArticleId><ArticleId IdType="pubmed">19144641</ArticleId></ArticleIdList></Reference><Reference><Citation>Patick AK, Binford SL, Brothers MA, et al. In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother. 1999;43(10):2444&#x2013;2450.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89498</ArticleId><ArticleId IdType="pubmed">10508022</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayden FG, Turner RB, Gwaltney JM, et al. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother. 2003;47(12):3907&#x2013;3916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC296196</ArticleId><ArticleId IdType="pubmed">14638501</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang PH. Characterization and inhibition of SARS-coronavirus main protease. Curr Top Med Chem. 2006;6(4):361&#x2013;376.</Citation><ArticleIdList><ArticleId IdType="pubmed">16611148</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Lin D, Kusov Y, et al. &#x3b1;-ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment. J Med Chem. 2020;63(9):4562&#x2013;4578.</Citation><ArticleIdList><ArticleId IdType="pubmed">32045235</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman RL, Kania RS, Brothers MA, et al. Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19. J Med Chem. 2020;63(21):12725&#x2013;12747.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571312</ArticleId><ArticleId IdType="pubmed">33054210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo CJ, Liu HG, Lo YK, et al. Individual and common inhibitors of coronavirus and picornavirus main proteases. FEBS Lett. 2009;583(3):549&#x2013;555.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7094298</ArticleId><ArticleId IdType="pubmed">19166843</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanchard JE, Elowe NH, Huitema C, et al. High-throughput screening identifies inhibitors of the SARS coronavirus main proteinase. Chem Biol. 2004;11(10):1445&#x2013;1453.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134594</ArticleId><ArticleId IdType="pubmed">15489171</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma C, Sacco MD, Hurst B, et al. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease. Cell Res. 2020;30(8):678&#x2013;692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7294525</ArticleId><ArticleId IdType="pubmed">32541865</ArticleId></ArticleIdList></Reference><Reference><Citation>Upla P, Marjomaki V, Nissinen L, et al. Calpain 1 and 2 are required for RNA replication of echovirus 1. J Virol. 2008;82:1581&#x2013;1590.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2224425</ArticleId><ArticleId IdType="pubmed">18032503</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozym RA, Patel K, White C, et al. Calcium signals and calpain-dependent necrosis are essential for release of coxsackievirus B from polarized intestinal epithelial cells. Mol Biol Cell. 2011;22:3010&#x2013;3021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3164450</ArticleId><ArticleId IdType="pubmed">21737691</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnard DL, Hubbard VD, Burton J, et al. Inhibition of severe acute respiratory syndrome-associated coronavirus (SARSCoV) by calpain inhibitors and beta-D-N4-hydroxycytidine. Antivir Chem Chemother. 2004;15(1):15&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">15074711</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider M, Ackermann K, Stuart M, et al. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol. 2012;86(18):10112&#x2013;10122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3446591</ArticleId><ArticleId IdType="pubmed">22787216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Worrall LJ, Vuckovic M, et al. Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site. Nat Commun. 2020;11:5877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7674412</ArticleId><ArticleId IdType="pubmed">33208735</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Xie W, Xue X, et al. Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biol. 2005;3(10):e324.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1197287</ArticleId><ArticleId IdType="pubmed">16128623</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YF, Nomoto A, Detjen BM, et al. A protein covalently linked to poliovirus genome RNA. Proc Natl Acad Sci U SA. 1977;74:59&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC393196</ArticleId><ArticleId IdType="pubmed">189316</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul AV, Peters J, Mugavero J, et al. Biochemical and genetic studies of the VPg uridylylation reaction catalyzed by the polymerase of poliovirus. J Virol. 2002;88(2):891&#x2013;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC140777</ArticleId><ArticleId IdType="pubmed">12502805</ArticleId></ArticleIdList></Reference><Reference><Citation>Egloff MP, Ferron F, Campanacci V, et al. Canard . The severe acute respiratory syndrome-coronavirus replicative protein nsp9 is a single-stranded RNA-binding subunit unique in the RNA virus world. Proc Natl Acad Sci U S A. 2004;101:3792&#x2013;3796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC374323</ArticleId><ArticleId IdType="pubmed">15007178</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone VM, Hankaniemi MM, Laitinen OH, et al. A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates. Sci Adv. 2020;6(19):eaaz2433.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202868</ArticleId><ArticleId IdType="pubmed">32494709</ArticleId></ArticleIdList></Reference><Reference><Citation>Goll DE, Thompson VF, Li H, et al. The calpain system. Physiol Rev. 2003. Jul;83(3):731&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pubmed">12843408</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon SY, Ha YE, Choi JE, et al. Coxsackievirus B4 uses autophagy for replication after calpain activation in rat primary neurons. J Virol. 2008. Dec;82(23):11976&#x2013;11978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2583648</ArticleId><ArticleId IdType="pubmed">18799585</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth M, Pettitt T, Symonds A, et al. Identification of the Pocket Factors in a Picornavirus. Arch Virol. 2003;148:1225&#x2013;1233.</Citation><ArticleIdList><ArticleId IdType="pubmed">12756627</ArticleId></ArticleIdList></Reference><Reference><Citation>Pevear DC, Tull TM, Seipel ME, et al. Activity of Pleconaril Against Enteroviruses. Antimicrob Agents Chemother. 1999;43:2109&#x2013;2115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC89431</ArticleId><ArticleId IdType="pubmed">10471549</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdelnabi R, Geraets JA, Ma Y, et al. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biol. 2019;17:e3000281.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6559632</ArticleId><ArticleId IdType="pubmed">31185007</ArticleId></ArticleIdList></Reference><Reference><Citation>Laskowski RA, Swindells MB. LigPlot+: multiple ligand&#x2013;protein interaction diagrams for drug discovery.J Chem Inform Model. 2011;51(10):2778&#x2013;2786.</Citation><ArticleIdList><ArticleId IdType="pubmed">21919503</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>